Can AXT, Inc. (AXTI) Stock Reach $90?

Key Takeaways

• The central $90 stock price target is the arithmetic mean of four recent, attributable analyst price targets, rounded from roughly $90.75.
• Analyst targets span a wide $55 to $125 range, reflecting sharply divided views on AXTI.
• With shares near $58, reaching $90 would require an upside move of roughly 55%, a substantial gain.
• Record indium phosphide (InP) demand tied to AI data centers is the strongest support for the bull case.
• China export-permit uncertainty, valuation, and rising in-house competition from customers are the largest risks.

Analyst Price Targets and Consensus View

AXT, Inc. (NASDAQ: AXTI) is a materials-science company that makes compound semiconductor substrate wafers, principally indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge). Recent attributable price targets from the sell side include $93 from Wedbush (Buy, reiterated July 31, 2026), $90 from UBS (Buy, July 31, 2026), $55 from B. Riley (Hold, July 31, 2026), and $125 from Northland Securities (Buy, July 30, 2026). The arithmetic mean of these four targets is about $90.75, which rounds to the $90 central target used here. The low-to-high range is unusually wide at $55 to $125, signaling real disagreement about how much of the AI-fueled demand story is already priced in.

The bullish targets are anchored to the company's explosive InP revenue growth and multi-year capacity expansion, while the cautious $55 target reflects concerns about valuation, export-permit timing, and the risk that customers eventually bring substrate supply in-house. This is not a tight consensus; it is a genuine split between growth-oriented and valuation-oriented views.

Current Market Position and Path Toward the Target

AXTI last closed near $58, down sharply from a 52-week high of $143.16 reached earlier in 2026, though still far above its 52-week low of $4.35. Reaching the $90 target would require an advance of about 55% from current levels, a substantial move that would not simply reflect mean reversion but a renewed expansion in investor expectations.

The fundamental path runs through InP capacity and revenue. AXT reported record Q2 2026 revenue of $47.6 million, up 164% year over year, with record InP revenue of $30.7 million. Non-GAAP earnings of $0.19 per share beat consensus estimates of $0.07 by a wide margin, and non-GAAP gross margin expanded to about 45%. Management said InP revenue opportunity is on track to more than triple by the end of 2026, with further significant expansion expected in 2027. Backlog surpassed $100 million, and the company holds roughly $748.8 million in cash after an April 2026 secondary offering.

What Could Support a Move Toward the Target

• Structural AI demand: InP substrates are critical for high-speed optical transceivers (800G and 1.6T) used in AI data centers.
• Capacity expansion: AXT is ahead of schedule on doubling InP capacity in 2026 and plans another major expansion in 2027.
• Long-term supply agreements with Casela, Coherent, and Lumentum, including prepayments, improve revenue visibility.
• Margin inflection: gross margin rose to about 45% on volume, mix, and productivity gains.
• Strong balance sheet: roughly $748.8 million in cash funds capacity build-out without immediate financing pressure.

What Could Prevent the Target From Being Reached

• Export permits: AXT depends on Chinese government permits to ship InP substrates; timing remains uncertain and could delay revenue.
• Valuation: shares trade at a premium multiple, and the stock has already surged roughly 325% year to date before its pullback.
• Competitive vertical integration: customers COHR and LITE are expanding their own InP production, which could reduce demand for AXT's wafers over time.
• Geopolitical and trade restrictions between the U.S. and China, where most of AXT's manufacturing is located.
• Execution risk tied to aggressive capacity investment and dilution from the recent secondary offering.

Technical Levels and Market Structure

AXTI's chart reflects an exceptional run followed by a sharp retracement. The 52-week high near $143 acts as a distant resistance level, while the stock's surge from about $4.35 to $143 means there are few meaningful historical support zones in the current range. The $55 level, roughly matching the lowest current analyst target, is a nearby area to watch, while the $90 target sits well below the prior high and represents a partial recovery of the 2026 advance.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though firms do not always state one explicitly, and horizons can vary. The most important near-term events are the company's next earnings report, scheduled for October 29, 2026, and any management updates on InP capacity, backlog, and gross margin. Investors should also track export-permit developments from China's Ministry of Commerce, new supply-agreement announcements, analyst target revisions, and progress by Coherent and Lumentum on internal InP capacity.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening alone. For investors tracking fast-moving AI-adjacent names like AXT, AI-powered signal tools can complement traditional research.

Final Assessment

The $90 central target is a calculated average of four recent analyst price targets, not a published consensus, and the $55-to-$125 range shows that analysts genuinely disagree about AXTI's path. Reaching $90 would require a roughly 55% advance from current levels, supported by record InP demand and accelerating capacity but challenged by export-permit risk, premium valuation, and customer vertical integration. The next earnings report and any permit news will be decisive in shaping whether sentiment moves the stock toward, or away from, that target.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations